Localization of cysteine protease, cathepsin S, to the surface of vascular smooth muscle cells by association with integrin αvβ3

American Journal of Pathology

Volumn 168, Issue 2, 2006, Pages 685-694

  Cheng, Xian Wu ^a,b   Kuzuya, Masafumi ^a   Nakamura, Kae ^a   Di, Qun ^a   Liu, Zexuan ^a   Sasaki, Takeshi ^a   Kanda, Shigeru ^a   Jin, Hai ^b   Shi, Guo Ping ^c   Murohara, Toyoaki ^a   Yokota, Mitsuhiro ^a   Iguchi, Akihisa ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YANBIAN UNIVERSITY   (China)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN S; CYSTATIN C; CYSTEINE PROTEINASE; ELASTIN; GAMMA INTERFERON; INTERLEUKIN 1BETA; PEPTIDE HYDROLASE INHIBITOR; RECEPTOR; VITRONECTIN RECEPTOR;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; BIOTINYLATION; CELL INVASION; CELL MEMBRANE; CELL MIGRATION; CELL SURFACE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; GEL; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INTIMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RAT; TUNICA MEDIA; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

EID: 33144488633     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.050295     Document Type: Article

References (30)

1. Brenner CA, Adler RR, Rappolee DA, Pedersen RA, Werb Z: Genes for extracellular-matrix-degrading metalloproteinases and their inhibitor, TIMP, are expressed during early mammalian development. Genes Dev 1989, 3:848-859
2. Pauly RR, Passaniti A, Bilato C, Monticone R, Cheng L, Papadopoulos N, Gluzband YA, Smith L, Weinstein C, Lakatta EG, Crow MT: Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. Circ Res 1994, 75:41-54
3. Lawrence DM, Singh RS, Franklin DP, Carey DJ, Elmore JR: Rapamycin suppresses experimental aortic aneurysm growth. J Vasc Surg 2004, 40:334-338
4. Mignatti P, Robbins E, Rifkin DB: Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell 1986, 47:487-498
5. Russell RE, Thorley A, Culpitt SV, Dodd S, Donnelly LE, Demattos C, Fitzgerald M, Barnes PJ: Alveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteases. Am J Physiol 2002, 283:L867-L873
6. Cheng XW, Kuzuya M, Sasaki T, Arakawa K, Kanda S, Sumi D, Koike T, Maeda K, Tamaya-Mori N, Shi GP, Saito N, Iguchi A: Increased expression of elastolytic cysteine proteases, cathepsins S and K, in the neointima of balloon-injured rat carotid arteries. Am J Pathol 2004, 164:243-251
7. Shi GP, Sukhova GK, Kuzuya M, Ye Q, Du J, Zhang Y, Pan JH, Lu ML, Cheng XW, Iguchi A, Perrey S, Lee AM, Chapman HA, Libby P: Deficiency of the cysteine protease cathepsin S impairs microvessel growth. Circ Res 2003, 92:493-500
8. Kuzuya M, Kanda S, Sasaki T, Tamaya-Mori N, Cheng XW, Itoh T, Itohara S, Iguchi A: Deficiency of gelatinase a suppresses smooth muscle cell invasion and development of experimental intimal hyperplasia. Circulation 2003, 108:1375-1381
9. Falkenberg M, Tom C, DeYoung MB, Wen S, Linnemann R, Dichek DA: Increased expression of urokinase during atherosclerotic lesion development causes arterial constriction and lumen loss, and accelerates lesion growth. Proc Natl Acad Sci USA 2002, 99:10665-10670
10. Sukhova GK, Shi GP, Simon DI, Chapman HA, Libby P: Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest 1998, 102:576-583
11. Sukhova GK, Zhang Y, Pan JH, Wada Y, Yamamoto T, Naito M, Kodama T, Tsimikas S, Witztum JL, Lu ML, Sakara Y, Chin MT, Libby P, Shi GP: Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice. J Clin Invest 2003, 111:897-906
12. Li Z, Yasuda Y, Li W, Bogyo M, Katz N, Gordon RE, Fields GB, Bromme D: Regulation of collagenase activities of human cathepsins by glycosaminoglycans. J Biol Chem 2004, 279:5470-5479
13. Chapman Jr HA, Stone OL, Vavrin Z: Degradation of fibrin and elastin by intact human alveolar macrophages in vitro. Characterization of a plasminogen activator and its role in matrix degradation. J Clin Invest 1984, 73:806-815
14. Yee C, Shiu RP: Degradation of endothelial basement membrane by human breast cancer cell lines. Cancer Res 1986, 46:1835-1839
15. Cheng XW, Kuzuya M, Sasaki T, Kanda S, Tamaya-Mori N, Koike T, Maeda K, Nishitani E, Iguchi A: Green tea catechins inhibit neointimal hyperplasia in a rat carotid arterial injury model by TIMP-2 overexpression. Cardiovasc Res 2004, 62:594-602
16. Kanda S, Kuzuya M, Ramos MA, Koike T, Yoshino K, Ikeda S, Iguchi A: Matrix metalloproteinase and alphavbeta3 integrin-dependent vascular smooth muscle cell invasion through a type I collagen lattice. Arterioscler Thromb Vasc Biol 2000, 20:998-1005
17. Strongin AY, Marmer BL, Grant GA, Goldberg GI: Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2. J Biol Chem 1993, 268:14033-14039
18. Puyraimond A, Fridman R, Lemesle M, Arbeille B, Menashi S: MMP-2 colocalizes with caveolae on the surface of endothelial cells. Exp Cell Res 2001, 262:28-36
19. Brooks PC, Stromblad S, Sanders LC, von Schalscha TL, Aimes RT, Stetler-Stevenson WG, Quigley JP, Cheresh DA: Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 1996, 85:683-693
20. Yasuda Y, Li Z, Greenbaum D, Bogyo M, Weber E, Bromme D: Cathepsin V: a novel and potent elastolytic activity expressed in activated macrophages. J Biol Chem 2004, 279:36761-36770
21. Hall A, Ekiel I, Mason RW, Kasprzykowski F, Grubb A: Abrahamson M. Structural basis for different inhibitory specificities of human cystatins C and D. Biochemistry 1998, 37:4071-4079
22. Deryugina EI, Ratnikov B, Monosov E, Postnova TI, DiScipio R, Smith JW, Strongin AY: MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells. Exp Cell Res 2001, 263:209-223
23. Ellerbroek SM, Fishman DA, Kearns AS, Bafetti LM, Stack MS: Ovarian carcinoma regulation of matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase through beta1 integrin. Cancer Res 1999, 59:1635-1641
24. Testa JE, Quigley JP: The role of urokinase-type plasminogen activator in aggressive tumor cell behavior. Cancer Metastasis Rev 1990, 9:353-367
25. Jormsjö S, Wuttge DM, Sirsjo A, Whatling C, Hamsten A, Stemme S, Eriksson P: Differential expression of cysteine and aspartic proteases during progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Pathol 2002, 161:939-945
26. Watari M, Watari H, DiSanto ME, Chacko S, Shi GP, Strauss III JF: Pro-inflammatory cytokines induce expression of matrix-metabolizing enzymes in human cervical smooth muscle cells. Am J Pathol 1999, 154:1755-1762
27. Punturieri A, Filippov S, Allen E, Caras I, Murray R, Reddy V, Weiss SJ: Regulation of elastinolytic cysteine proteinase activity in normal and cathepsin K-deficient human macrophages. J Exp Med 2000, 192:789-799
28. Beers C, Honey K, Fink S, Forbush K, Rudensky A: Differential regulation of cathepsin S and cathepsin L in interferon gamma-treated macrophages. J Exp Med 2003, 197:169-179
29. Shi GP, Webb AC, Foster KE, Knoll JH, Lemere CA, Munger JS, Chapman HA: Human cathepsin S: chromosomal localization, gene structure, and tissue distribution. J Biol Chem 1994, 269:11530-11536
30. Piali L, Hammel P, Uherek C, Bachmann F, Gisler RH, Dunon D, Imhof BA: CD31/PECAM-1 is a ligand for alpha v beta 3 integrin involved in adhesion of leukocytes to endothelium. J Cell Biol 1995, 130:451-460